Takeda Archives - Page 12 of 15 -

Alofisel recommended for complex perianal fistulas in Crohn’s disease

First ever ‘off the shelf’ stem cell therapy nears European approval

https://pharmaphorum.com/news/tigenixtakeda-stem-cell-therapy-backed-eu-regulators/

Digital/ Digital and Social Media/ News/ News

Takeda depression app impresses in pilot study

Marco Ricci Apple Watch, depression, digital health, Takeda, wearables 0 Comment

App corresponds with standard cognitive and patient-reported assessment measures.

Takeda depression app impresses in pilot study

https://pharmaphorum.com/news/takeda-depression-app-pilot/

Healthcare/ Partner content/ Press releases

Spotlight on Key Sessions at SMi’s 3rd Annual Lyophilization USA

Pavan Solanki clinical trials, freeze-drying, lyophilization, Takeda 0 Comment

Hear from Industry Experts on Key Sessions

Spotlight on Key Sessions at SMi’s 3rd Annual Lyophilization USA

https://pharmaphorum.com/partner-content/spotlight-on-key-sessions-at-smis-3rd-annual-lyophilization-usa/

Healthcare/ News/ UK & Europe

Adcetris cleared by NICE in aggressive blood cancer

Richard Staines blood cancer, cancer, market access, NICE, non-Hodgkin lymphoma, Takeda 0 Comment

NICE has recommended regular NHS funding for Takeda’s Adcetris in an aggressive type of non-Hodgkin lymphoma after the

Adcetris cleared by NICE in aggressive blood cancer

https://pharmaphorum.com/news/takedas-adcetris-cleared-nhs-funding-aggressive-blood-cancer/

AstraZeneca/ News/ R&D

AZ to develop Parkinson’s drug with Takeda

Richard Staines AstraZeneca, neurology, Parkinson's disease, R&D, Takeda 0 Comment

AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market

AZ to develop Parkinson’s drug with Takeda

https://pharmaphorum.com/news/az-develop-parkinsons-drug-takeda/

News/ R&D

Samsung Bioepis signs R&D agreement with Takeda

Richard Staines endocrinology, R&D, Samsung Bioepis, Takeda 0 Comment

South Korean firm looking to develop novel drugs

Samsung Bioepis signs R&D agreement with Takeda

https://pharmaphorum.com/news/samsung-bioepis-signs-rd-agreement-takeda/

News/ R&D

Takeda begins new R&D link-up with Molecular Templates

Richard Staines Biotech, cancer, R&D, Takeda 0 Comment

Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates. The Japanese

Takeda begins new R&D link-up with Molecular Templates

https://pharmaphorum.com/news/takeda-begins-new-rd-link-molecular-templates/

News/ R&D

Seattle, Takeda aim for first line Adcetris use

Richard Staines cancer, classical Hodgkin lymphoma, Seattle Genetics, Takeda 0 Comment

Seattle CEO hopes Adcetris will be standard of care.

Seattle, Takeda aim for first line Adcetris use

https://pharmaphorum.com/news/takeda-seattle-adcetris/

Cancer/ News/ R&D

AZ highlights data from next-gen oncology drugs at ASCO

Richard Staines ASCO17, AstraZeneca, blood cancer, breast cancer, lung cancer, Oncology, ovarian cancer, Takeda, Tesaro 0 Comment

Tesara and Takeda among other companies to publish data.

AZ highlights data from next-gen oncology drugs at ASCO

https://pharmaphorum.com/news/az-highlights-data-next-gen-oncology-drugs-asco/

Trending

Takeda

Login